Medindia LOGIN REGISTER
Medindia

Repurposed Amyotrophic Lateral Sclerosis (ALS) Drug Against Rare Genetic Disorder

by Karishma Abhishek on Nov 21 2021 8:55 AM

Repurposed ALS (amyotrophic lateral sclerosis) drug may help slow down a rare genetic disorder in children and adolescents.

Repurposed Amyotrophic Lateral Sclerosis (ALS) Drug Against Rare Genetic Disorder
Riluzole, a repurposed ALS (amyotrophic lateral sclerosis) drug may help slow down a rare genetic disorder called Niemann-Pick disease type C1 (NPC1 – characterized by the gradual loss of a particular brain cell) in children and adolescents, as per a new study in mice at the National Institutes of Health, published in Molecular Genetics and Metabolism.
NPC1 occurs due to an impaired ability to move cholesterol through cells. This leads to difficulty in controlling movements, liver and lung disease, impaired swallowing, intellectual decline, and death, as a result of gradual loss of brain cells known as Purkinje neurons.

The present study found that on treating the NPC1 mice riluzole, there was an improved survival of 12% longer as compared to untreated mice.

This showed that riluzole or similar drugs may help slow down the disease progression in NPC1patients.



Source-Medindia


Advertisement

Home

Consult

e-Book

Articles

News

Calculators

Drugs

Directories

Education